Last Updated:
ED visits Vedanta and Hindustan Zinc offices, Canara Bank okays Rs 8,500 crore capital plan, IndiGo to halt Manchester flights, Concord Biotech gets USFDA nod
Stocks To Watch Today, June 3.
Stocks To Watch, June 03: Indian equity benchmarks are likely to see a muted start on Wednesday, with GIFT Nifty trading 10 points lower at 23,482.5 as of 7:50 AM, indicating a flat-to-negative opening for the NSE Nifty 50.
Asian markets, on the other hand, hit a record high, downplaying the concerns over stalled Iran-US peace negotiations.
Some stocks will remain in focus due to multiple corporate reasons:
Vedanta, Hindustan Zinc share price in focus
The Enforcement Directorate (ED) visited certain offices of Vedanta and its subsidiary Hindustan Zinc. The company said it is extending full cooperation to the authorities and is providing all information sought.
Canara Bank share price in focus
The lender’s board has approved a capital-raising plan of up to Rs 8,500 crore for FY27. The bank intends to raise up to Rs 4,500 crore through Basel III-compliant Additional Tier-I bonds and up to Rs 4,000 crore through Tier-II bonds.
IndiGo share price in focus
IndiGo will temporarily suspend flight operations to and from Manchester from August 31, 2026, citing prolonged international airspace constraints, higher flight durations, and a challenging cost environment. The airline also plans to return one of its leased Boeing 787-9 Dreamliner aircraft to Norse Atlantic Airways.
Concord Biotech share price in focus
The company has received USFDA approval for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL, used in preventing organ rejection in transplant patients.
NHPC share price in focus
The government’s Offer for Sale (OFS) in NHPC was subscribed 3.47 times by non-retail investors on the first day, prompting the Centre to exercise the full 3% greenshoe option.
Dhanuka Agritech share price in focus
The company’s Rs 70 crore share buyback offer will open on June 4. Under the buyback, Dhanuka Agritech plans to repurchase up to 5 lakh shares at Rs 1,400 apiece.
Bliss GVS Pharma share price in focus
The company’s Palghar manufacturing facility in Maharashtra has received an Inspection Closure Report from the World Health Organization, confirming compliance with WHO Good Manufacturing Practices (GMP) standards.
About the Author
Varun Yadav is a Sub Editor at News18 Business Digital. He writes articles on markets, personal finance, technology, and more. He completed his post-graduation diploma in English Journalism from the I…Read More
Read More
Source link
[ad_3]
